Meta AI Soars to Nearly 1 Billion Monthly Users

Published 1 days agoMETA

Meta AI Soars to Nearly 1 Billion Monthly Users

Meta's AI assistant has witnessed remarkable growth, amassing close to 1 billion monthly active users across its suite of apps. Launched in September 2023, the assistant swiftly became part of Facebook, Instagram, WhatsApp, Messenger, and a dedicated web app, which played a crucial role in its rapid uptake, according to a report by Moneycontrol.

By August 2024, Meta AI had already surpassed 400 million monthly active users, with about 185 million interacting on a weekly basis, as reported by The Information. In early 2025, CEO Mark Zuckerberg was optimistic about reaching more than 1 billion users by the year's end, rising from last year’s 600 million monthly figures noted by Indian Express.

On the strategic front, Meta has planned to invest up to $65 billion in AI infrastructure throughout 2025. This includes building expansive data centers and utilizing Nvidia's AI chips, with a target of deploying over 1.3 million graphics processors by the year's end, Reuters reported. To bolster revenue, Meta is exploring the introduction of a premium AI tier and embedding ads, further positioning its AI as a formidable rival to the likes of OpenAI's ChatGPT and Google’s Gemini.

Share this article

Twitter Facebook LinkedIn

Recent Articles

Ulta Beauty Lifts Annual Profit Forecast on Robust Consumer Demand

Ulta Beauty Lifts Annual Profit Forecast on Robust Consumer Demand

9 minutes agoULTA

Ulta Beauty has adjusted its annual profit forecast upwards following a strong quarterly performance, emphasizing robust consumer demand and successful brand introductions. The company's net sales hit $2.85 billion, outpacing analyst expectations of $2.79 billion. Similarly, comparable sales grew by 2.9%, marked by a 2.3% increase in average ticket size and a 0.6% rise in transactions, while adjusted profit per share reached $6.70, significantly above the predicted $5.81. The retailer now anticipates an annual profit per share ranging from $22.65 to $23.20, a clear hike from its previous estimate of $22.50 to $22.90. This optimistic outlook is supported by the successful launch of new products like Milk Makeup and K-Beauty lines, along with a surge in foot traffic from younger consumers drawn to trendy and affordable brands such as Elf Beauty. Celebrity-endorsed products, especially Fenty Beauty, have also contributed to this positive trend, bolstering Ulta's market position. Reuters reported that Ulta continues to face challenges in the luxury segment largely due to tariff uncertainties. Nevertheless, its strategic investments in digital and marketing initiatives, alongside a steady portfolio of trendy offerings, have enabled Ulta Beauty to navigate these hurdles effectively. Looking ahead, the company envisions a modest growth for fiscal 2025, with comparable sales predicted to range from stable to a slight increase of 1.5%.

Danaher and AstraZeneca Propel AI Advancements in Healthcare

Danaher and AstraZeneca Propel AI Advancements in Healthcare

24 minutes agoDHR

Danaher Corporation and AstraZeneca are spearheading significant advancements in the fields of precision medicine and AI diagnostics, albeit through separate collaborations rather than a joint partnership. Danaher, through its diagnostic and investment arms, teamed up with Innovaccer Inc. in early 2025 to integrate AI into healthcare, aiming to improve patient outcomes via precision diagnostics. This strategic move enhances Danaher's capacity to support value-based care environments effectively. In a separate initiative, AstraZeneca has entered into an $18 million collaboration with Immunai Inc., a company renowned for its AI expertise in the immune system domain. Announced in September 2024, this partnership targets cancer drug trials, utilizing Immunai's AI platform to refine clinical decisions around dose selection and biomarker identification. This collaboration underscores AstraZeneca's commitment to leveraging advanced technology in enhancing the effectiveness of cancer treatments. Both Danaher and AstraZeneca are committed to harnessing AI in healthcare, highlighting separate yet pivotal roles each company plays in the evolution of precision medicine. Despite their parallel endeavors, Reuters reported that there is no current collaboration directly linking these two powerhouses in the healthcare sector.

Gap Inc. Shares Plummet on Tariff Concerns Despite Strong Sales

Gap Inc. Shares Plummet on Tariff Concerns Despite Strong Sales

39 minutes agoGPS

Gap Inc. witnessed a sharp drop in its stock price, falling 15% during after-hours trading, despite surpassing first-quarter sales expectations. This decline reflects investor concerns over the potential financial hit from U.S. tariffs, which could adversely affect the company's gross margins in the upcoming quarter. Reuters highlighted that these concerns emerged even as Gap reported better-than-expected results, driven by strong demand for its Old Navy and namesake brands. The retailer anticipates a financial impact from tariffs amounting to between $250 million and $300 million. However, Gap plans to counteract more than half of these added costs through strategic initiatives, striving to soften the blow on its earnings. For the recent quarter, Gap recorded a 2.2% rise in revenue to $3.46 billion and earnings of 51 cents per share, both figures outperforming analyst projections. Nonetheless, fears over tariffs loom large, with Gap reiterating its fiscal 2025 outlook of 1% to 2% sales growth and 8% to 10% operating income growth, excluding tariff implications. On a positive note, sourcing less than 10% of its merchandise from China could help the company alleviate tariff-related pressures. This strategic supply chain diversification might serve as a buffer against the full brunt of the tariffs, according to analysts cited by TipRanks.

Costco Shows Strong Earnings Despite Consumer Confidence Dip

Costco Shows Strong Earnings Despite Consumer Confidence Dip

54 minutes agoCOST

Costco Wholesale Corporation has delivered impressive financial results in its latest quarter, demonstrating resilience even as consumer confidence wanes. The retailer reported a net income of $5.29 per share, surpassing the expected $5.15 per share, according to Reuters. Overall revenue climbed by 7.5% to $62.15 billion, exceeding analysts' forecasts. Supporting this performance, Costco's same-store sales increased by 5.4%, bolstered by a steady demand in consumables and groceries. When excluding the effects of fuel and currency changes, this figure rises to 9.1%, highlighting strong fundamental growth. As reported by MSM Times, Costco expanded its operations by adding 40 to 50 new locations, bringing its total to 897 warehouses globally. Additionally, the company's membership renewal rates remain robust, with 93% in the U.S. and Canada and 90.5% worldwide as of early March 2025. Costco has successfully captured changes in consumer behavior, with a noted shift from dining out to eating at home enhancing sales in categories like meat and produce, as noted by TheStreet. Such trends align well with Costco's value-centric approach, contributing to ongoing customer loyalty and solid financial performance. As of May 29, 2025, Costco's shares are trading at $1,008.74, reflecting continued investor confidence in the company's strategic positioning and market resilience.